{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Medical Oncology Department, Institut Català d’Oncologia L’Hospitalet, Barcelona, Spain",
    "Carolina BioOncology Institute, Huntersville, NC, USA",
    "Department of Drug Development and Innovation, Institut Curie, Paris-Saclay University, Paris, France",
    "AbbVie, South San Francisco, CA, USA",
    "Department of Medical Oncology, Centre Léon Bérard, Lyon, France",
    "AbbVie Inc., North Chicago, IL, USA",
    "Prisma Health Cancer Institute, Greenville, SC, USA",
    "Virginia Cancer Specialists, Fairfax, VA, USA",
    "The START Center for Cancer Research, San Antonio, TX, USA",
    "National Cheng Kung University Hospital, Tainan, Taiwan",
    "National Cancer Center Hospital East, Kashiwa, Japan",
    "START Madrid-FJD, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain",
    "National Taiwan University Hospital, Taipei, Taiwan",
    "National Cancer Center Hospital, Tokyo, Japan",
    "Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "Stanford University and Stanford Cancer Institute, Stanford, CA, USA"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 24,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Marc Oliva"
    },
    {
      "affs": [
        1
      ],
      "name": "John Powderly"
    },
    {
      "affs": [
        2
      ],
      "name": "Christophe Le Tourneau"
    },
    {
      "affs": [
        3
      ],
      "name": "Amani Makkouk"
    },
    {
      "affs": [
        4
      ],
      "name": "Philippe A. Cassier"
    },
    {
      "affs": [
        5
      ],
      "name": "Maulik Patel"
    },
    {
      "affs": [
        6
      ],
      "name": "Ki Chung"
    },
    {
      "affs": [
        7
      ],
      "name": "Alexander Spira"
    },
    {
      "affs": [
        8
      ],
      "name": "Amita Patnaik"
    },
    {
      "affs": [
        9
      ],
      "name": "Wu-Chou Su"
    },
    {
      "affs": [
        10
      ],
      "name": "Toshihiko Doi"
    },
    {
      "affs": [
        11
      ],
      "name": "Victor Moreno"
    },
    {
      "affs": [
        12
      ],
      "name": "Chia-Chi Lin"
    },
    {
      "affs": [
        13
      ],
      "name": "Toshio Shimizu"
    },
    {
      "affs": [
        14,
        15
      ],
      "name": "Sonali Jindal"
    },
    {
      "affs": [
        14,
        15
      ],
      "name": "Padmanee Sharma"
    },
    {
      "affs": [
        0
      ],
      "name": "Agostina Stradella"
    },
    {
      "affs": [
        3
      ],
      "name": "Jaehyung Hong"
    },
    {
      "affs": [
        3
      ],
      "name": "John Engelhardt"
    },
    {
      "affs": [
        3
      ],
      "name": "Martha Blaney"
    },
    {
      "affs": [
        3
      ],
      "name": "Tolga Turan"
    },
    {
      "affs": [
        3
      ],
      "name": "Luija Wang"
    },
    {
      "affs": [
        3
      ],
      "name": "Michael A. McDevitt"
    },
    {
      "affs": [
        16
      ],
      "name": "A. Dimitrios Colevas"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/8bfrge1t2vaxg.bib",
  "cited_by": 0,
  "doi": "10.1080/14796694.2026.2736946",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13733580/",
  "id": "8bfrge1t2vaxg",
  "issns": [
    "1479-6694",
    "1744-8301"
  ],
  "landing_url": "https://doi.org/10.1080/14796694.2026.2736946",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7224416031",
  "pdf_url": null,
  "pmcid": "PMC13733580",
  "pmid": "42956185",
  "published": "2026-10-29",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/8bfrge1t2vaxg.ris",
  "sources": [
    {
      "first_seen": "2026-11-08T12:23:19Z",
      "native_id": "PMC13733580",
      "source": "pmc",
      "url": "https://doi.org/10.1080/14796694.2026.2736946"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "Phase 1 study of OX40 agonist ABBV-368 as monotherapy or in combination with budigalimab in advanced solid tumors",
  "title_text": "Phase 1 study of OX40 agonist ABBV-368 as monotherapy or in combination with budigalimab in advanced solid tumors",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T12:23:19Z",
  "url": "https://research.draconitic.com/paper/8bfrge1t2vaxg",
  "venue": "Future Oncology",
  "versions": []
}